» Articles » PMID: 32625165

Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience

Overview
Journal Front Neurol
Specialty Neurology
Date 2020 Jul 7
PMID 32625165
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2 is a novel coronavirus leading to serious respiratory disease and is spreading around the world at a raging speed. Recently there is emerging speculations that the central nervous system (CNS) may be involved during SARS-CoV-2 infection, contributing to the respiratory failure. However, the existence of viral replication in CNS has not been confirmed due to the lack of evidence from autopsy specimens. Considering the tropism of SARS-CoV-2, ACE2, is prevailing in CNS, and the neuro-invasive property of human coronavirus was widely reported, there is a need to identified the possible complications during COVID-19 for CNS. In this review, we conduct a detailed summary for the potential of SARS-CoV-2 to infect central nervous system from latest biological fundamental of SARS-CoV-2 to the clinical experience of other human coronaviruses. To confirm the neuro-invasive property of SARS-CoV-2 and the subsequent influence on patients will require further exploration by both virologist and neurologist.

Citing Articles

CNS Viral Infections-What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches.

Sun M, Manson M, Guo T, de Lange E CNS Drugs. 2024; 38(5):349-373.

PMID: 38580795 PMC: 11026214. DOI: 10.1007/s40263-024-01082-3.


Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis.

Fajar J, Ilmawan M, Mamada S, Mutiawati E, Husnah M, Yusuf H Narra J. 2024; 1(3):e48.

PMID: 38450213 PMC: 10914045. DOI: 10.52225/narra.v1i3.48.


Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease.

Park S, Conti L, Franceschi V, Oh B, Yang M, Ham G Front Immunol. 2023; 14:1197649.

PMID: 37483612 PMC: 10358724. DOI: 10.3389/fimmu.2023.1197649.


Neuroinflammation in Dementia-Therapeutic Directions in a COVID-19 Pandemic Setting.

Luc M, Wozniak M, Rymaszewska J Cells. 2022; 11(19).

PMID: 36230921 PMC: 9562181. DOI: 10.3390/cells11192959.


Clinical characteristics of 365 hospitalized COVID-19 patients with neurological symptoms: an observational study.

Vahabizad F, Togha M, Ariyanfar S, Fattahi M, Haghighi S, Ebadi Z Acta Neurol Belg. 2022; 123(5):1805-1811.

PMID: 36008590 PMC: 9409615. DOI: 10.1007/s13760-022-02027-7.


References
1.
Cabeca T, Granato C, Bellei N . Epidemiological and clinical features of human coronavirus infections among different subsets of patients. Influenza Other Respir Viruses. 2013; 7(6):1040-7. PMC: 4634278. DOI: 10.1111/irv.12101. View

2.
Harmer D, Gilbert M, Borman R, Clark K . Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002; 532(1-2):107-10. DOI: 10.1016/s0014-5793(02)03640-2. View

3.
Tian J, Shi R, Liu T, She R, Wu Q, An J . Brain Infection by Hepatitis E Virus Probably via Damage of the Blood-Brain Barrier Due to Alterations of Tight Junction Proteins. Front Cell Infect Microbiol. 2019; 9:52. PMC: 6436201. DOI: 10.3389/fcimb.2019.00052. View

4.
Netland J, Meyerholz D, Moore S, Cassell M, Perlman S . Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008; 82(15):7264-75. PMC: 2493326. DOI: 10.1128/JVI.00737-08. View

5.
Vabret A, Dina J, Brison E, Brouard J, Freymuth F . [Human coronaviruses]. Pathol Biol (Paris). 2008; 57(2):149-60. PMC: 7125620. DOI: 10.1016/j.patbio.2008.02.018. View